BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2014 3:52:00 PM | Browse: 1248 | Download: 1009
 |
Received |
|
2013-05-28 09:44 |
 |
Peer-Review Started |
|
2013-05-29 15:47 |
 |
To Make the First Decision |
|
2013-06-24 10:20 |
 |
Return for Revision |
|
2013-07-01 13:43 |
 |
Revised |
|
2013-07-30 23:29 |
 |
Second Decision |
|
2013-09-17 09:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-09-17 10:45 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-04-21 10:49 |
 |
Publish the Manuscript Online |
|
2014-05-07 10:10 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Autobiography |
Article Title |
Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma
|
Manuscript Source |
Invited Manuscript |
All Author List |
Frank Serge Lehmann, Francesca Trapani, Ida Fueglistaler, Luigi Maria Terracciano, Markus von Flüe, Gieri Cathomas, Andreas Zettl, Pascal Benkert, Daniel Oertli and Christoph Beglinger |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Unrestricted research |
to Dr. Lehmann FS |
Pfizer AG, Viollier Laboratories AG, Switzerland performed the fecal calprotectin assays |
|
|
Corresponding Author |
Frank Serge Lehmann, MD, Division of Gastroenterology and Hepatology, University Hospital, Petersgraben 4, 4031 Basel, Switzerland. fslehmann@hin.ch |
Key Words |
Calprotectin; Colorectal cancer; Inflammation; Tumor size; Granulocytes |
Core Tip |
Colorectal cancer (CRC) patients have a significant increase of fecal calprotectin release. The mechanisms for this observation are unclear. In our study, we examined the calprotectin release before and after operation of 46 CRC patients. This is the first study that assessed the correlation of calprotectin with both tumor as well as histopathological parameters. Our study contains the following new information: (1) the release of calprotectin is exclusively correlated to the T-stage, but to no histopathological parameters; and (2) except the T-stage, all other tumor characteristics assessed by the seventh edition of the tumor node metastasis classification are not correlated. |
Publish Date |
2014-05-07 10:10 |
Citation |
Lehmann FS, Trapani F, Fueglistaler I, Terracciano LM, von Flüe M, Cathomas G, Zettl A, Benkert P, Oertli D, Beglinger C. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma. World J Gastroenterol 2014; 20(17): 4994-4999 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i17/4994.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i17.4994 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345